Drug Target Review

Drug development has changed. Bioanalysis is changing with it

2026-06-24T07:00:00+01:00By Dr Abdul Basit Shaikh

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How is the field adapting to meet these new demands?

Article
Small tags, big advances: studying endogenous proteins in their native context
2026-06-22T07:00:00+01:00By Dr Joshua Sopp
By combining CRISPR knock-in with small peptide tags, researchers can study proteins in their native cellular context, generating more predictive data for translational drug discovery.
Article
Cerebral organoids reveal how Ebola virus persists in neural tissue
2026-06-18T16:01:00+01:00By Drug Target Review
How does Ebola virus survive long after recovery? A new study using human cerebral organoids explores viral persistence in neural tissue and the growing role of organoid models in drug discovery research.
Article
Pomegranate-derived compound shows therapeutic potential in heart disease
2026-06-15T07:00:00+01:00Contributor Professor Dipak Ramji, By Drug Target Review
Researchers at Cardiff University have identified urolithin A – a compound produced by gut bacteria during the metabolism of substances found in pomegranates – as a potential new approach for treating cardiovascular disease.

Opinion and interviews

Physics-based modelling offers a new way to study drug targets

2026-03-26T14:15:00+00:00By Drug Target Review

Australian start-up OmnigeniQ has demonstrated what it describes as the first deterministic, physics-based computation of a human protein in its native state.

From scientist to bioinformatician: how AI coding tools dissolved the activation energy barrier
2026-03-19T09:00:00+00:00
How self-driving labs are changing drug development
2026-03-09T09:00:00+00:00
Why PDE4B matters in the search for better IPF and PPF therapies
2026-02-27T09:05:00+00:00
AI in drug discovery: predictions for 2026
2026-02-16T09:00:00+00:00
Making science run at the speed of thought: the reality of AI in drug discovery – Part 2
2025-11-25T09:01:00+00:00

Webinar

Where NAMs stand in early drug discovery: an expert discussion

2026-06-24T13:00:002026-06-24T13:00:002026-06-24T14:00:00Sponsored by HUB Organoids

Webinar

From expert task to lab routine – Membrane protein purification and analysis simplified

2026-06-30T14:00:002026-06-30T14:00:002026-06-30T15:00:00Sponsored by Analytik Jena GmbH + Co. KG

A new way to tackle the most challenging drug targets: Discover a fully automated, detergent-free purification workflow that isolates membrane proteins in their native 3D structure in as little as three hours and with minimal hands-on time. Learn how to perform subsequent digital miniaturization and qPCR-based stability analysis with compact solutions that integrate seamlessly into your lab.